# Oracain

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oracain

- Industry: Pharmaceuticals
- Headquarters: Denmark
- Website: www.oracain.com
- Latest round: Series A (Aug 1, 2011)
- Investors on record: 2

## About

Oracain is a specialized platform focused on domain name sales and branding services, providing innovative solutions for businesses looking to establish their digital identity.Founded in 2011 in Denmark, Oracain operates primarily in the realm of domain sales and associated branding services. The company has not undergone significant shifts in its operational strategy since inception. Oracain was established by a team of entrepreneurs committed to enhancing online branding for businesses. The company has completed 2 deals, with the most recent funding round occurring on August 1, 2011, when it raised funds from returning investors DTU Symbion Innovation and SEED Capital Denmark.Oracain.com specializes in domain name sales and associated branding services, offering a comprehensive platform for businesses seeking to establish their online presence. The company's core offerings include access to a diverse inventory of over 300,000 expert-curated, brandable domains, including one-word domains with modern extensions such as .ai, .io, and .xyz. In addition to domain sales, Oracain provides an array of branding solutions, including logo design services, AI-powered name generators, and trademark protection. These tools are designed to assist startups, small businesses, and established brands in creating memorable identities and protecting their intellectual property. Oracain's services cater primarily to the North American and European markets, addressing the needs of entrepreneurs, marketing professionals, and corporations looking to enhance their digital footprint.Oracain generates revenue through the sale of domain names and associated branding services. The company's transactions typically involve direct sales to consumers—primarily businesses seeking to purchase premium domain names. Each transaction is facilitated through the Atom.com marketplace, where customers can instantly purchase domains for a set price, in this case, USD 2,911 for the Oracain.com domain. Additionally, Oracain offers managed naming contests and branding consultations, which may involve service fees based on the complexity and scope of the branding initiatives. The company's revenue model is structured around providing value-added services that complement domain acquisition, ensuring a seamless experience for clients while fostering long-term relationships through ongoing branding support. The EBITDA for the most recent year, 2023, stands at USD -25,253.90.Oracain is exploring several initiatives for future growth. The company is in the process of designing new branding tools aimed at enhancing user experience, with expected releases planned throughout 2024. Additionally, Oracain is targeting expansion into the Asian market, with plans to establish a presence there by the end of 2025. The funding from the Series A round in August 2011 will be utilized to support these product developments and market expansion efforts.

## Funding rounds

- Series A, Aug 1, 2011 — PreSeed Ventures, SEED Capital
- Seed, Jan 1, 2011 — PreSeed Ventures, SEED Capital

## Investors

- PreSeed Ventures (https://capitalatlas.ai/funds/preseed-ventures) — Seed, Series A
- SEED Capital (https://capitalatlas.ai/funds/seed-capital) — Seed, Series A